May 19, 2022

Novavax data suggests its COVID-19 vaccine is highly effective

Vaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico.

The vaccine was about 90% effective overall and preliminary data showed it was safe, the company said.

While demand for COVID-19 shots in the U.S. has dropped off dramatically, the need for more vaccines around the world remains critical. The Novavax vaccine, which is easy to store and transport, is expected to play an important role in boosting vaccine supplies in the developing world.

That help is still months away, however. The company says it plans to seek authorization for the shots in the U.S., Europe and elsewhere by the end of September and be able to produce up to 100 million doses a month by then.

“Many of our first doses will go to … low- and middle-income countries, and that was the goal to begin with,” Novavax Chief Executive Stanley Erck told The Associated Press.

While more than half of the U.S. population has had at least one COVID-19 vaccine dose, less than 1 percent of people in the developing world have had one shot, according to Our World In Data.

Novavax’s study involved nearly 30,000 people ages 18 and up in the U.S. and Mexico. Two-thirds received two doses of the vaccine, three weeks apart, and the rest got dummy shots.

There were 77 cases of COVID-19 — 14 in the group that got the vaccine and the rest were in volunteers who received dummy shots. None in the vaccine group had moderate or severe disease, compared to 14 in the placebo group.

The vaccine was similarly effective against several variants including the one first detected in the U.K. that’s dominant in the U.S., and in high-risk populations including the elderly and people with other health problems.

Side effects were mostly mild — tenderness and pain at the injection site. There were no reports of unusual blood clots or heart problems, Erck said.

Novavax reported the results in a press release and plans to publish in a medical journal, where it will be vetted by independent experts. The Maryland-based company previously released findings from smaller studies in Britain and South Africa.

COVID-19 vaccines train the body to recognize the coronavirus, especially the spike protein that coats it, and get ready to fight the virus off. The Novavax vaccine is made with lab-grown copies of that protein. That’s different from some of the other vaccines now widely used, which include genetic instructions for the body to make its own spike protein.

The Novavax vaccine can be stored in standard refrigerators, making it easier to distribute.

Novavax previously announced manufacturing delays due to supply shortages. The company now expects to reach production of 100 million doses a month by the end of September and 150 million doses a month by December.

The company has committed to supplying 110 million doses to the U.S. over the next year and a total of 1.1 billion doses to developing countries.

In May, vaccines alliance Gavi announced it had signed an agreement to buy 350 million doses of Novavax’s vaccine, with deliveries estimated to begin in the third quarter. COVAX, the global initiative to provide vaccines to countries, is facing a critical shortage of vaccines after its biggest supplier in India suspended exports until the end of the year.

Novavax has been working on developing vaccines for more than three decades, but hasn’t brought one to market. The company’s coronavirus vaccine work is partly funded by the U.S. government.

in Health
Related Posts

Many cancer patients pay dearly for hospital parking

May 18, 2021

May 18, 2021

For cancer patients, the road from diagnosis to survivorship feels like a never-ending parade of medical appointments: surgeries, bloodwork, chemotherapy,...

Dr. Fauci on Delta variant, booster shots and masks for the vaccinated

June 29, 2021

June 29, 2021

Anthony Fauci: Well, it certainly is a game changer, Judy, for people who are not vaccinated. One of the issues...

Hundreds of bodies found buried along Indian riverbanks

May 16, 2021

May 16, 2021

PRAYAGRAJ, India — Police are reaching out to villagers in northern India to investigate the recovery of bodies buried in...

US life expectancy sees ‘massive’ decline, especially in Black and brown communities

June 24, 2021

June 24, 2021

A new study found that between 2018 and 2020, U.S. life expectancy decreased by the biggest margin since world war...

Juul to pay $40 million in North Carolina teen vaping suit settlement

June 28, 2021

June 28, 2021

DURHAM N.C. (AP) — Electronic cigarette giant Juul Labs Inc. will pay $40 million to North Carolina and take more...

California to drop social distancing requirements in June

May 21, 2021

May 21, 2021

SACRAMENTO, Calif. (AP) — California no longer will require social distancing and will allow full capacity for businesses when the...

Nursing homes can now lift most COVID restrictions on visits

November 13, 2021

November 13, 2021

WASHINGTON (AP) — The government on Friday directed nursing homes to open their doors wide to visitors, easing many remaining...

WHO says Delta is ‘most transmissible’ COVID-19 variant identified so far

June 25, 2021

June 25, 2021

LONDON (AP) — The head of the World Health Organization said the COVID-19 delta variant, first seen in India, is...

IMF projects US economy to grow 7% due to robust vaccinations, but warns of inflation

July 1, 2021

July 1, 2021

Kristalina Georgieva: It is very important for everyone everywhere. Why? Because what we are facing in the world is a...

Nearly all COVID deaths in US are now among unvaccinated

June 24, 2021

June 24, 2021

Nearly all COVID-19 deaths in the U.S. now are in people who weren’t vaccinated, a staggering demonstration of how effective...

Highly contagious Delta variant on path to become dominant strain in the US

June 29, 2021

June 29, 2021

William Brangham: Even the U.S., with nearly half its population vaccinated, and as people ditch masks and pack back into...

U.S. COVID-19 deaths hit 600,000, equal to yearly cancer toll

June 15, 2021

June 15, 2021

The U.S. death toll from COVID-19 topped 600,000 on Tuesday, even as the vaccination drive has drastically brought down daily...

A Brief But Spectacular take on breaking the script in healthcare

June 7, 2021

June 7, 2021

Judy Woodruff: Carey Candrian is a Colorado-based social scientist. She’s spent much of her career investigating how health care can...

E.U. braces for tough winter as citizens protest COVID restrictions

November 22, 2021

November 22, 2021

Trent Murray: Sunday was not a day of rest in the Belgian capital, Brussels. Riot police ringed the headquarters of...

WATCH: White House COVID-19 Task Force gives pandemic update

May 21, 2021

May 21, 2021

The White House COVID-19 Task Force met as the nation’s vaccine rollout continues and the rate of new infections declines....